Apolipoprotein E isoprotein-specific interactions with tissue plasminogen activator

被引:16
作者
Biehle, SJ
Carrozzella, J
Shukla, R
Popplewell, J
Swann, M
Freeman, N
Clark, JF
机构
[1] Univ Cincinnati, Med Ctr, Dept Neurol, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Dept Environm Hlth, Ctr Biostat Serv, Cincinnati, OH 45221 USA
[3] Farfield Sensors Ltd, Unit 51, Salford M6 6AJ, Lancs, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2004年 / 1689卷 / 03期
关键词
apolipoprotein E; tissue plasminogen activator; thrombolysis; protein-protein interaction; mechanism; dual polarization interferometry;
D O I
10.1016/j.bbadis.2004.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E (Apo E) is an important genetic risk factor for multiple neurological, vascular and cardiovascular diseases. Previously, we reported Apo E isoprotein-specific modulation of tissue plasminogen activator (tPA) using an in vitro blood-clotting assay. Here, we studied the conformational changes of Apo E2, E3 and E4 in the presence of tPA and vice versa using circular dichroism (CD) and dual polarization interferometry (DPI). We report isoprotein and state-specific intermolecular interactions between the Apo E isoforms and tPA. Apo E2 interaction with immobilized tPA leads to significant conformational changes which are not observed with Apo E3 or E4. Additionally, tPA induces changes in helicity of lipidated Apo E2 whereas no detectible changes were observed in Apo E3 or E4. The Tukey's test for interaction indicated a significant (P < 0.001) interaction between tPA and Apo E2 in the lipidated environment. These results may be important regarding the mechanism by which Apo E has isoprotein-specific effects on many biological processes and diseases involving blood clotting, proteolysis and perfusion. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 48 条
  • [1] Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism
    Acharya, P
    Segall, ML
    Zaiou, M
    Morrow, J
    Weisgraber, KH
    Phillips, MC
    Lund-Katz, S
    Snow, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1584 (01): : 9 - 19
  • [2] Hospital charges for stroke patients
    Alberts, MJ
    Bennett, CA
    Rutledge, VR
    [J]. STROKE, 1996, 27 (10) : 1825 - 1828
  • [3] Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1 - The distance between P3 and P1' determined by donor-donor fluorescence energy transfer
    Aleshkov, SB
    Fa, M
    Karolin, J
    Strandberg, L
    Johansson, LBA
    Wilczynska, M
    Ny, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) : 21231 - 21238
  • [4] Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides
    Bazin, HG
    Marques, MA
    Owens, AP
    Linhardt, RJ
    Crutcher, KA
    [J]. BIOCHEMISTRY, 2002, 41 (25) : 8203 - 8211
  • [5] The Greater Cincinnati Northern Kentucky Stroke Study - Preliminary first-ever and total incidence rates of stroke among blacks
    Broderick, J
    Brott, T
    Kothari, R
    Miller, R
    Khoury, J
    Pancioli, A
    Gebel, J
    Mills, D
    Minneci, L
    Shukla, R
    [J]. STROKE, 1998, 29 (02) : 415 - 421
  • [6] Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Broderick, J
    Lu, M
    Jackson, C
    Pancioli, A
    Tilley, BC
    Fagan, SC
    Kothari, R
    Levine, SR
    Marler, JR
    Lyden, PD
    Haley, EC
    Brott, T
    Grotta, JC
    [J]. ANNALS OF NEUROLOGY, 2001, 49 (06) : 736 - 744
  • [7] Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA Stroke Trial
    Broderick, JP
    Lu, M
    Kothari, R
    Levine, SR
    Lyden, PD
    Haley, EC
    Brott, TG
    Grotta, J
    Tilley, BC
    Marler, JR
    Frankel, M
    [J]. STROKE, 2000, 31 (10) : 2335 - 2341
  • [8] Isoforms of apolipoprotein E can modulate TPA-induced clot lysis in vitro
    Clark, JF
    Huri, DA
    Carrozzella, J
    Jauch, EC
    Mehta, P
    Heaton, D
    Biehle, SJ
    Broderick, JP
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : A163 - A168
  • [9] PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE
    CORDER, EH
    SAUNDERS, AM
    RISCH, NJ
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    RIMMLER, JB
    LOCKE, PA
    CONNEALLY, PM
    SCHMADER, KE
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. NATURE GENETICS, 1994, 7 (02) : 180 - 184
  • [10] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923